CELLDEX THERAPEUTICS

Serial Number 77668007
Registration 3753874
800

Registration Progress

Application Filed
Feb 11, 2009
Under Examination
Approved for Publication
Dec 15, 2009
Published for Opposition
Dec 15, 2009
Registered
Mar 2, 2010

Trademark Image

CELLDEX THERAPEUTICS

Basic Information

Serial Number
77668007
Registration Number
3753874
Filing Date
February 11, 2009
Registration Date
March 2, 2010
Published for Opposition
December 15, 2009
Renewal Date
March 2, 2020
Drawing Code
3000

Status Summary

Current Status
Active
Status Code
800
Status Date
Oct 19, 2020
Registration
Registered
Classes
005

Rights Holder

Celldex Therapeutics, Inc.

03
Address
53 Frontage Road, Suite 220
Hampton, NJ 08827

Ownership History

Celldex Therapeutics, Inc.

Original Applicant
03
Needham, MA

Celldex Therapeutics, Inc.

Owner at Publication
03
Needham, MA

Celldex Therapeutics, Inc.

Original Registrant
03
Hampton, NJ

Legal Representation

Attorney
Vanessa A. Ignacio, Esq.

USPTO Deadlines

Next Deadline
1538 days remaining
Section 8 & 9 Renewal Due (Principal Register) (20-Year) (Based on R.PRA event 2010-03-02)
Due Date
March 02, 2030
Grace Period Ends
September 02, 2030
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

37 events
Date Code Type Description Documents
Oct 19, 2020 NA89 E NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED Loading...
Oct 19, 2020 RNL1 Q REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS) Loading...
Oct 19, 2020 89AG O REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED Loading...
Oct 19, 2020 APRE A CASE ASSIGNED TO POST REGISTRATION PARALEGAL Loading...
Aug 31, 2020 E89R I TEAS SECTION 8 & 9 RECEIVED Loading...
Mar 2, 2019 REM2 E COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED Loading...
Aug 6, 2015 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Aug 6, 2015 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
Apr 24, 2015 NA85 E NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED Loading...
Apr 24, 2015 C15A O REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. Loading...
Apr 24, 2015 APRE A CASE ASSIGNED TO POST REGISTRATION PARALEGAL Loading...
Apr 13, 2015 E815 I TEAS SECTION 8 & 15 RECEIVED Loading...
Mar 2, 2010 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Dec 15, 2009 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Dec 15, 2009 PUBO A PUBLISHED FOR OPPOSITION Loading...
Nov 9, 2009 PREV O LAW OFFICE PUBLICATION REVIEW COMPLETED Loading...
Nov 6, 2009 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Nov 6, 2009 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Nov 6, 2009 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Nov 6, 2009 GNEA O EXAMINERS AMENDMENT E-MAILED Loading...
Nov 6, 2009 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Nov 2, 2009 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Nov 2, 2009 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Nov 2, 2009 GNEA O EXAMINERS AMENDMENT E-MAILED Loading...
Nov 2, 2009 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Oct 26, 2009 ACEC I AMENDMENT FROM APPLICANT ENTERED Loading...
Oct 26, 2009 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Oct 23, 2009 MAIL I PAPER RECEIVED Loading...
May 6, 2009 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
May 6, 2009 GNRT F NON-FINAL ACTION E-MAILED Loading...
May 6, 2009 CNRT R NON-FINAL ACTION WRITTEN Loading...
May 4, 2009 DMCC I DATA MODIFICATION COMPLETED Loading...
May 4, 2009 ALIE A ASSIGNED TO LIE Loading...
May 1, 2009 DOCK D ASSIGNED TO EXAMINER Loading...
Feb 18, 2009 MDSC O NOTICE OF DESIGN SEARCH CODE MAILED Loading...
Feb 17, 2009 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Feb 14, 2009 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Purified proteins and pharmaceuticals for therapeutic use, all for use in the treatment of cardiovascular disease, immune disorders and inflammation
First Use Anywhere: Jan 12, 2009
First Use in Commerce: Jan 12, 2009

Additional Information

Design Mark
The mark consists of an oval design with a letter Y" inside separating the oval into three quadrants; the wording "CELLDEX" is to the right with the wording "THERAPEUTICS" below "CELLDEX".
Color Claim
Color is not claimed as a feature of the mark.

Classification

International Classes
005

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
General Disclaimer
"THERAPEUTICS"